相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature
Henk B. Luiting et al.
BJU INTERNATIONAL (2020)
Moderately Hypofractionated Radiotherapy in Node-positive Prostate Cancer
I Mallick et al.
CLINICAL ONCOLOGY (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group
Hester Lieng et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer
Attapol Pinitpatcharalert et al.
ADVANCES IN RADIATION ONCOLOGY (2019)
Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review
Antonino Battaglia et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
Nicholas G. Zaorsky et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J. Roach et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection
Firas Abdollah et al.
EUROPEAN UROLOGY (2018)
Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial
Abdenour Nabid et al.
EUROPEAN UROLOGY (2018)
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life
Hima Bindu Musunuru et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer
Naresh Jegadeesh et al.
CANCER (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Prostate-Specific Membrane Antigen Positron Emission Tomographye-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning
Sandeep K. Gupta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer
Annika Herlemann et al.
EUROPEAN UROLOGY (2016)
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer Data From Patients in the Control Arm of the STAMPEDE Trial
Nicholas D. James et al.
JAMA ONCOLOGY (2016)
A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High- Risk Prostate Cancer
Glenn Bauman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
Malcolm D. Mason et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer
Chun Chieh Lin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists
Thomas P. Shakespeare
RADIATION ONCOLOGY (2015)
Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer
Chun Chieh Lin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study
Chad G. Rusthoven et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival
Jonathan D. Tward et al.
PRACTICAL RADIATION ONCOLOGY (2013)
RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH-RISK PROSTATE CANCER
Colleen A. F. Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of Phase III RTOG 85-31
MV Pilepich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Androgen suppression plus radiation versus radiation alone for patients with stage D1/Pathologic node-positive adenocarcinoma of the prostate:: Updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31
CA Lawton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation therapy oncology group 9413
M Roach et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer
GK Zagars et al.
UROLOGY (2001)
分享论文
